216 related articles for article (PubMed ID: 32107582)
1. Apparent diffusion coefficient value of mass-forming intrahepatic cholangiocarcinoma: a potential imaging biomarker for prediction of lymph node metastasis.
Zhou Y; Zhou G; Gao X; Xu C; Wang X; Xu P
Abdom Radiol (NY); 2020 Oct; 45(10):3109-3118. PubMed ID: 32107582
[TBL] [Abstract][Full Text] [Related]
2. Mass-forming intrahepatic cholangiocarcinoma: Can diffusion-weighted imaging predict microvascular invasion?
Zhou Y; Wang X; Xu C; Zhou G; Liu X; Gao S; Xu P
J Magn Reson Imaging; 2019 Jul; 50(1):315-324. PubMed ID: 30444023
[TBL] [Abstract][Full Text] [Related]
3. Value of diffusion-weighted MR imaging in the diagnosis of lymph node metastases in patients with cholangiocarcinoma.
Holzapfel K; Gaa J; Schubert EC; Eiber M; Kleeff J; Rummeny EJ; Loos M
Abdom Radiol (NY); 2016 Oct; 41(10):1937-41. PubMed ID: 27271285
[TBL] [Abstract][Full Text] [Related]
4. A multi-center diagnostic system for intrahepatic mass-forming cholangiocarcinoma based on preoperative MRI and clinical features.
Sheng R; Zhang Y; Wang H; Zhang W; Jin K; Sun W; Dai Y; Zhou J; Zeng M
Eur Radiol; 2024 Jan; 34(1):548-559. PubMed ID: 37552257
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the diagnostic performance of apparent diffusion coefficient (ADC) values on diffusion-weighted magnetic resonance imaging (DWI) in differentiating between benign and metastatic lymph nodes in cases of cholangiocarcinoma.
Promsorn J; Soontrapa W; Somsap K; Chamadol N; Limpawattana P; Harisinghani M
Abdom Radiol (NY); 2019 Feb; 44(2):473-481. PubMed ID: 30151713
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Diagnosis of Lymph Node Metastasis of Perihilar Cholangiocarcinoma Using Diffusion-Weighted Magnetic Resonance Imaging.
Hosokawa I; Hayano K; Furukawa K; Takayashiki T; Kuboki S; Takano S; Matsubara H; Miyazaki M; Ohtsuka M
Ann Surg Oncol; 2022 Sep; 29(9):5502-5510. PubMed ID: 35639292
[TBL] [Abstract][Full Text] [Related]
7. A preoperative scoring system to predict lymph node metastasis in intrahepatic cholangiocarcinoma.
Rhee H; Lim HJ; Han K; Yeom SK; Choi SH; Park JH; Cho ES; Park S; Lee MJ; Choi GH; Han DH; Lee SS; Park MS
Hepatol Int; 2023 Aug; 17(4):942-953. PubMed ID: 36689090
[TBL] [Abstract][Full Text] [Related]
8. Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it's not all about size.
Kolck J; Auer TA; Walter-Rittel T; Hosse C; Elkilany A; Marth AA; Pelzer U; Mohr R; Krenzien F; Lurje G; Schöning W; Hamm B; Geisel D; Fehrenbach U
Abdom Radiol (NY); 2023 Oct; 48(10):3063-3071. PubMed ID: 37354262
[TBL] [Abstract][Full Text] [Related]
9. Volumetric Apparent Diffusion Coefficient Histogram Analysis in Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Hepatocellular Carcinoma.
Zou X; Luo Y; Li Z; Hu Y; Li H; Tang H; Shen Y; Hu D; Kamel IR
J Magn Reson Imaging; 2019 Apr; 49(4):975-983. PubMed ID: 30277628
[TBL] [Abstract][Full Text] [Related]
10. Machine learning-based Radiomics analysis for differentiation degree and lymphatic node metastasis of extrahepatic cholangiocarcinoma.
Tang Y; Yang CM; Su S; Wang WJ; Fan LP; Shu J
BMC Cancer; 2021 Nov; 21(1):1268. PubMed ID: 34819043
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted imaging as an imaging biomarker for assessing survival of patients with intrahepatic mass-forming cholangiocarcinoma.
Promsorn J; Eurboonyanun K; Chadbunchachai P; Apivatanasiri C; Wirasorn K; Chindaprasirt J; Sookprasert A; Harisinghani M
Abdom Radiol (NY); 2022 Aug; 47(8):2811-2821. PubMed ID: 35704070
[TBL] [Abstract][Full Text] [Related]
12. Histogram analysis of diffusion-weighted magnetic resonance imaging as a biomarker to predict LNM in T3 stage rectal carcinoma.
Zhou Y; Yang R; Wang Y; Zhou M; Zhou X; Xing J; Wang X; Zhang C
BMC Med Imaging; 2021 Nov; 21(1):176. PubMed ID: 34809615
[TBL] [Abstract][Full Text] [Related]
13. The value of Gd-BOPTA- enhanced MRIs and DWI in the diagnosis of intrahepatic mass-forming cholangiocarcinoma.
Xu CC; Tang YF; Ruan XZ; Huang QL; Sun L; Li J
Neoplasma; 2017; 64(6):945-953. PubMed ID: 28895422
[TBL] [Abstract][Full Text] [Related]
14. A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features.
Shen K; Mo W; Wang X; Shi D; Qian W; Sun J; Yu R
Eur Radiol; 2023 Dec; 33(12):8986-8998. PubMed ID: 37392232
[TBL] [Abstract][Full Text] [Related]
15. CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.
Jiao CY; Zhang H; Ji GW; Xu Q; Lu M; Zhang B; Yang Y; Wang XH; Li XC
Eur Radiol; 2022 Dec; 32(12):8326-8338. PubMed ID: 35708837
[TBL] [Abstract][Full Text] [Related]
16. A Nomogram of Combining IVIM-DWI and MRI Radiomics From the Primary Lesion of Rectal Adenocarcinoma to Assess Nonenlarged Lymph Node Metastasis Preoperatively.
Jia H; Jiang X; Zhang K; Shang J; Zhang Y; Fang X; Gao F; Li N; Dong J
J Magn Reson Imaging; 2022 Sep; 56(3):658-667. PubMed ID: 35090079
[TBL] [Abstract][Full Text] [Related]
17. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
[TBL] [Abstract][Full Text] [Related]
18. Interpretable machine learning-based clinical prediction model for predicting lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
Xie H; Hong T; Liu W; Jia X; Wang L; Zhang H; Xu C; Zhang X; Li WL; Wang Q; Yin C; Lv X
BMC Gastroenterol; 2024 Apr; 24(1):137. PubMed ID: 38641789
[TBL] [Abstract][Full Text] [Related]
19. Apparent Diffusion Coefficient MRI Shows Association With Early Progression of Unresectable Intrahepatic Cholangiocarcinoma With Combined Targeted-Immunotherapy.
Sheng R; Sun W; Huang X; Jin K; Gao S; Zeng M; Wu D; Shi G
J Magn Reson Imaging; 2023 Jan; 57(1):275-284. PubMed ID: 35488518
[TBL] [Abstract][Full Text] [Related]
20. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
Fasmer KE; Gulati A; Dybvik JA; Ytre-Hauge S; Salvesen Ø; Trovik J; Krakstad C; Haldorsen IS
Eur Radiol; 2020 May; 30(5):2443-2453. PubMed ID: 32034487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
